MANTUANO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.235
AS - Asia 1.042
EU - Europa 1.006
SA - Sud America 276
AF - Africa 58
OC - Oceania 8
Totale 4.625
Nazione #
US - Stati Uniti d'America 2.144
IT - Italia 488
SG - Singapore 430
BR - Brasile 219
CN - Cina 202
HK - Hong Kong 111
RU - Federazione Russa 100
VN - Vietnam 74
SE - Svezia 68
DE - Germania 66
CA - Canada 62
FR - Francia 60
FI - Finlandia 54
GB - Regno Unito 53
BD - Bangladesh 45
IN - India 40
ES - Italia 25
CI - Costa d'Avorio 24
ID - Indonesia 24
NL - Olanda 24
JP - Giappone 22
MX - Messico 21
AR - Argentina 13
IQ - Iraq 13
PL - Polonia 11
TR - Turchia 11
ZA - Sudafrica 11
UZ - Uzbekistan 10
AT - Austria 9
PK - Pakistan 9
CO - Colombia 8
PE - Perù 8
AU - Australia 7
EC - Ecuador 7
SA - Arabia Saudita 7
UA - Ucraina 7
EG - Egitto 6
MA - Marocco 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
BE - Belgio 4
BO - Bolivia 4
CL - Cile 4
DZ - Algeria 4
JO - Giordania 4
KE - Kenya 4
KG - Kirghizistan 4
LT - Lituania 4
PH - Filippine 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DK - Danimarca 3
KR - Corea 3
MY - Malesia 3
PY - Paraguay 3
UY - Uruguay 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
EE - Estonia 2
GR - Grecia 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
BH - Bahrain 1
CR - Costa Rica 1
GA - Gabon 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LC - Santa Lucia 1
LV - Lettonia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 4.625
Città #
Ashburn 273
Singapore 251
San Jose 173
Fairfield 172
Chandler 159
Dallas 139
Hong Kong 106
Woodbridge 104
Bari 101
Milan 85
Cambridge 81
Beijing 72
Houston 71
Nyköping 65
Seattle 63
Wilmington 57
Los Angeles 46
Council Bluffs 40
Helsinki 40
Bitetto 38
New York 36
Bitonto 29
Victoria 27
Lauterbourg 26
Abidjan 24
Rome 24
Ann Arbor 22
Ho Chi Minh City 22
Jakarta 20
Lawrence 18
Santa Clara 18
Roxbury 17
São Paulo 17
Hanoi 16
Munich 16
Brooklyn 15
Des Moines 15
Taranto 15
Falkenstein 14
Montreal 14
Columbus 13
Grottaglie 13
Inglewood 13
Frankfurt am Main 12
Chennai 11
Chicago 11
Turku 11
Buffalo 10
London 10
Mexico City 10
Tokyo 10
Amsterdam 9
Boardman 9
Nuremberg 9
Orem 9
Rio de Janeiro 9
Tashkent 9
Denver 8
San Diego 8
Toronto 8
Atlanta 7
Belo Horizonte 7
Campinas 7
Nanjing 7
North Bergen 7
The Dalles 7
Trieste 7
Warsaw 7
Dong Ket 6
Groningen 6
Johannesburg 6
Shanghai 6
Turin 6
Brno 5
Jiaxing 5
Nakano 5
Naples 5
Poplar 5
Portsmouth 5
Redwood City 5
Sennori 5
Aldeatejada 4
Ankara 4
Baghdad 4
Bauru 4
Brescia 4
Brussels 4
Dublin 4
Figino 4
Goiânia 4
Haiphong 4
Jeddah 4
Luton 4
Melbourne 4
Mumbai 4
Nanchang 4
Paris 4
Pescara 4
Phoenix 4
Santa Maria 4
Totale 2.945
Nome #
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 339
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 290
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 243
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 235
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 231
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 230
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 213
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 194
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 155
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 155
Alteration of stim1/orai1-mediated soce in skeletal muscle: Impact in genetic muscle diseases and beyond 148
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity 146
Synthetic lethality to overcome cancer drug resistance 142
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 142
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds 141
"The Social Network" and Muscular Dystrophies: The Lesson Learnt about the Niche Environment as a Target for Therapeutic Strategies 131
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 122
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 122
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 119
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 114
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 114
Effect of exercise on telomere length and telomere proteins expression in mdx mice 101
Determination of qPCR reference genes suitable for normalizing gene expression in a novel model of Duchenne muscular dystrophy, the D2-mdx mouse 98
Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions 95
null 93
Synergistic antiproliferative and antiangiogenic effects of EGFR and mTOR inhibitors 89
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 85
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 83
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 79
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 57
On the use of D2.B10-Dmdmdx/J (D2.mdx) Versus C57BL/10ScSn-Dmdmdx/J (mdx) Mouse Models for Preclinical Studies on Duchenne Muscular Dystrophy: A Cautionary Note from Members of the TREAT-NMD Advisory Committee on Therapeutics 55
Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine 52
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 46
PRE-CLINICAL ASSESSMENT OF THE ROLE OF THE COMPLEMENT SYSTEM IN TRIGGERING FIBROSIS IN DUCHENNE MUSCULAR DYSTROPHY: TOWARDS NOVEL THERAPEUTIC TARGETS 37
A two-site collaborative study of electrical impedance myography for evaluation of disease progression in murine Duchenne muscular dystrophy models 25
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 20
Novel insights into the effects of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: A preclinical study in the D2-mdx mouse model. 16
Natural history study of the D2-mdx mouse for Duchenne muscular dystrophy: a comparison across two independent study sites 7
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 7
Validation of exploratory biomarkers of sarcopenia in community-dwelling older adults: insights from the IN-TEMPO clinical trial. 6
254PActivation of complement cascade may trigger inflammation and fibrosis in Duchenne muscular dystrophy: a preclinical investigation on two murine models 6
Diaphragm‐specific effects of L‐citrulline in mdx mice highlight its potential as adjuvant of standard therapy in Duchenne muscular dystrophy 5
Electrical impedance myography as a tool for monitoring disease progression in mouse models of Duchenne Muscular Dystrophy: a longitudinal, multisite study 5
Branched-chain amino acid supplementation in a mouse model of ageing: Effects on age-related kidney fibrosis 4
Totale 4.797
Categoria #
all - tutte 17.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022180 16 13 3 1 2 15 18 0 16 16 31 49
2022/2023356 26 52 26 38 29 43 2 41 56 5 21 17
2023/2024179 8 34 8 14 15 34 2 14 4 16 10 20
2024/2025882 32 6 26 28 31 101 157 109 55 54 112 171
2025/20262.285 338 78 256 173 248 102 218 80 296 226 105 165
2026/2027109 109 0 0 0 0 0 0 0 0 0 0 0
Totale 4.797